Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112898192B details a mild palladium-catalyzed carbonylation route for N-acyl indoles, offering cost reduction in API manufacturing and scalable production.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering reliable supply chain solutions and cost reduction in API manufacturing.
Patent CN109867632B details a safe copper-catalyzed route to 1,2,3-triazoles using diazonium salts, offering high yields and avoiding explosive azides for reliable supply.
Novel patent CN110218227A offers mild conditions for aryl ketone derivatives ensuring supply chain reliability and cost reduction for pharmaceutical intermediates manufacturing.
Patent CN110577520B reveals a green, high-yield route for 6-nitro-4-substituted amino quinazoline. Ideal for reliable API intermediate supply chains.
Patent CN114920707B reveals a novel iodine-promoted synthesis using DMF as both solvent and carbon source, offering significant cost reduction in API manufacturing and streamlined supply chains.
Patent CN113105402B reveals a metal-free iodine-promoted route for trifluoromethyl-triazoles, offering cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN113683595B reveals sulfur-promoted triazole synthesis. Offers cost reduction and scalable manufacturing for high-purity pharmaceutical intermediates supply chains.
Novel patent CN115286578B enables metal-free room temperature synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN101967075A details a mild inorganic base method for terminal alkyne synthesis, offering cost reduction and scalable supply chain solutions for pharma intermediates.
Patent CN112759595B details a novel Pd-catalyzed asymmetric allylation for chiral nucleosides, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Patent CN111925308B reveals a mild iridium-catalyzed photocatalytic route for N-substituted sulfone diimines, offering reliable pharmaceutical intermediate supply chains.
Patent CN115353511A details a novel multi-component synthesis of carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles. High yield, mild conditions, scalable for pharma intermediates.
Patent CN112538054B reveals a novel Pd-catalyzed carbonylation route for 1,2,4-triazole-3-ones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel Pd-catalyzed radical tandem cyclization for fluoroalkyl-substituted pyrrole[1,2-a]indoles. Green, efficient route reducing costs in API manufacturing.
Patent CN112142713A reveals a novel anhydride-mediated route for Imazethapyr, offering high purity, reduced waste, and scalable manufacturing for global agrochemical supply chains.
Patent CN114160206B reveals a novel chiral copper catalyst enabling high-yield, enantioselective synthesis of indole pharmaceutical intermediates with superior purity.
Patent CN112694430B reveals a novel Pd-catalyzed bis-carbonylation route for 1,5-dihydro-2H-pyrrol-2-one compounds, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN101628904B details a Mn(OAc)3-promoted synthesis. Offers high yield, mild conditions, and green solvent usage for pharmaceutical intermediates.